Novartis expands patient recruitment capabilities in deal with TrialSpark

Through a new partnership with TrialSpark (New York), Novartis AG (NYSE:NVS; SIX:NOVN) will build capacity to enhance clinical trial recruitment by creating local trial sites in areas where distance from hospitals prevents participation.

Through cloud-based data capture and analysis, TrialSpark's platform identifies patient recruitment hot spots -- areas where there are high numbers of potential participants but are unreasonable distances from clinical trial sites...